Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
D-erythro-Sphingosine
Cat. No.:
0225LY-1088
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
D-erythro-Sphingosine acts as an inhibitor of protein kinase C and serves as an activator of PP2A.
Synonym:
Trans-4-Sphingenine; Erythro-C18-Sphingosine; Erythrosphingosine; 123-78-4; Sphingosine; D-Sphingosine; 4-Sphingenine; Sphing-4-enine; Sphingenine; 4-trans-Sphingenine; (4E)-Sphingenine; (2S,3R,4E)-2-Amino-4-octadecene-1,3-diol; trans-D-erythro-2-Amino-4-octadecene-1,3-diol; D-erythro-Sphingosine (synthetic); (E,2S,3R)-2-aminooctadec-4-ene-1,3-diol; 4-octadecene-1,3-diol, 2-amino-, (2S,3R,4E)-; trans-4-Sphingenine; dl-Erythro-sphingosine; Erythro-dl-sphingosine; Sphingoid; c18-erythro-sphingenine; (2S,3R)-Sphingosine; (2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol; C18-Sphingosine; D-erythro-C18-Sphingosine; (-)-D-erythro-Sphingosine; (-)-Sphingosine; (2S,3R,E)-2-aminooctadec-4-ene-1,3-diol; (E)-2-Amino-4-octadecan-1,3-diol
CAS No.:
123-78-4
Compound CID:
5280335
Formula:
C18H37NO2
Formula Weight:
299.49
Specification
Targets&IC50:
p32: 8 μM (EC50)
Relative Density:
0.939 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
D-erythro-Sphingosine can be used in lipid signaling research to study its role as a precursor for ceramide and its effects on cell growth.
Library Information
Target:
PKC; Phosphatase
Receptor:
Phosphatase; PKC; PP2A
Pathways:
Cytoskeletal signaling; Chromatin/Epigenetic; Metabolism
Plate Number:
AOCL-15
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
42.08 mg/mL; 140.51 mM





